Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China
· Delayed Price · Currency is CNY 46.49
+0.12 (0.26%)
At close: Dec 5, 2025
Tianjin Pharmaceutical Da Ren Tang Group Corporation Company Description
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs.
The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022.
The company was founded in 1981 and is based in Tianjin, the People’s Republic of China.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
| Country | China |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,619 |
| CEO | Lei Wang |
Contact Details
Address: Darentang Building Tianjin, 300193 China | |
| Phone | 86 22 2702 0598 |
| Website | jydrt.com.cn |
Stock Details
| Ticker Symbol | 600329 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001808 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Lei Wang | Chairman of the Board |
| Jian Ma | Chief Financial Officer |
| Hong Zhou | Deputy GM, Chief Engineer and Executive Director |
| Min Guo | Executive Director |
| Yu Zhang | Chief Manufacturing Officer |
| Mingjie Shang | Executive Director |
| Yan Jiao | Secretary to the Board of Directors |